Northwestern Mutual Wealth Management
RARE icon

Northwestern Mutual Wealth Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Sell
30
-429
-93% -$10.7K ﹤0.01% 3784
2026
Q1 		$9.62K Buy
459
+429
+1,430% +$9.66K ﹤0.01% 3082
2025
Q4 		$690 Hold
30
– – ﹤0.01% 3682
2025
Q3 		$902 Sell
30
-126
-81% -$3.78K ﹤0.01% 3571
2025
Q2 		$5.67K Buy
156
+103
+194% +$3.71K ﹤0.01% 2973
2025
Q1 		$1.92K Buy
+53
New +$2.21K ﹤0.01% 3164
2024
Q4 		– Sell
-22
Closed -$1.22K – 3834
2024
Q3 		$1.22K Buy
+22
New +$1.12K ﹤0.01% 3207
2024
Q1 		– Sell
-10
Closed -$478 – 3773
2023
Q4 		$478 Sell
10
-90
-90% -$3.49K ﹤0.01% 3281
2023
Q3 		$3.56K Buy
+100
New +$3.96K ﹤0.01% 2831
2023
Q2 		– Sell
-5
Closed -$201 – 3557
2023
Q1 		$201 Buy
+5
New +$215 ﹤0.01% 3185
2022
Q3 		– Sell
-60
Closed -$4K – 3341
2022
Q2 		$4K Buy
+60
New +$3.69K ﹤0.01% 2789
2022
Q1 		– Sell
-50
Closed -$4K – 3342
2021
Q4 		$4K Buy
+50
New +$4.07K ﹤0.01% 2851
2016
Q4 		– Sell
-4
Closed – – 2480
2016
Q3 		$0 Buy
+4
New +$255 ﹤0.01% 2301

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Northwestern Mutual Wealth Management's RARE Position: Q2 2026 in Review

Northwestern Mutual Wealth Management reduced its Ultragenyx Pharmaceutical (RARE) stake by 93% in Q2 2026, selling an estimated $10.7K and leaving 30 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #3784.

Northwestern Mutual Wealth Management first reported a position in RARE in Q3 2016 and has held it in 13 quarters since. The position peaked at $9.62K in Q1 2026. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Northwestern Mutual Wealth Management held 30 shares of Ultragenyx Pharmaceutical worth $1K as of Q2 2026.
  • Northwestern Mutual Wealth Management sold 429 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $10.7K.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3784 holding.
  • Northwestern Mutual Wealth Management first reported a position in Ultragenyx Pharmaceutical in Q3 2016 and has held it in 13 quarters since.
  • Northwestern Mutual Wealth Management's Ultragenyx Pharmaceutical position peaked at $9.62K in Q1 2026.
  • 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.